Prosecution Insights
Last updated: November 20, 2026

Marissa Envenesia Taylor, USPTO Patent Examiner

Listed by the USPTO as TAYLOR, MARISSA ENVENESIA

Tech Center 3700 • Art Units: 3783

This examiner grants 78% of resolved cases

Analysis

TAYLOR, MARISSA ENVENESIA is assigned to Tech Center 3700 and Art Unit 3783. The profile covers 32 resolved cases, with a 78.1% allowance rate and a 30.4% interview lift. The median time to allowance is 1335 days. The limited resolved-case base requires caution in drawing broad conclusions, but the available data support considering interviews during prosecution planning.

The listed companies are Terumo Corporation, Cardinal Health Inc., and Becton, Dickinson and Company. The listed firms are Maschoff Brennan (OC)(BD), Bookoff McAndrews, PLLC, and BUCHANAN, INGERSOLL & ROONEY PC. These entries provide useful technology and counsel context. Practitioners should combine that context with application-specific analysis rather than treating the historical figures as dispositive.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

78.1%
Allow Rate
+8.1% vs TC avg
61
Total Applications
+30.4%
Interview Lift
1335
Avg Prosecution Days
Based on 32 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
29.5%
§102 Novelty
45.1%
§103 Obviousness
23.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18086090 MEDICAL DEVICE ADAPTED FOR MULTIPLE IMPLANT RECAPTURES Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18237756 CATHETER AND METHOD FOR MANUFACTURING SAME Final Rejection TERUMO KABUSHIKI KAISHA
17933150 LOCK ADAPTER, SYRINGE ASSEMBLY, AND PREFILLED SYRINGE Non-Final OA TERUMO KABUSHIKI KAISHA
18360717 FLUID CONNECTOR ASSEMBLY Final Rejection CareFusion 303, Inc.
17952746 INTRAVENOUS SET WITH PUMP INTERFACE FOR RAPID INFUSION VIA REUSABLE DRIVER Final Rejection CareFusion 303, Inc.
17767111 DRUG DELIVERY DEVICE Non-Final OA AMGEN INC.
18924403 CO-LOCATION CRADLE FOR AUTOMATED MEDICAMENT DELIVERY SYSTEMS AND ANALYTE SENSORS AND DEPLOYMENT THEREOF Non-Final OA Insulet Corporation
18841746 Hydraulic Block for Dialysis, Hydraulic System for Dialysis and Method for Manufacturing Hydraulic Block Non-Final OA Fresenius Medical Care Deutschland GmbH
18157922 MEDICAL DEVICE WITH A FOUR- LEAD THREAD, LUER CONNECTOR Final Rejection Becton, Dickinson and Company
18092791 SMART OBTURATOR ASSEMBLY Final Rejection Becton, Dickinson and Company
18835193 GAS TRAP DEVICE Non-Final OA TESSEN SOLUTIONS LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Marissa Envenesia Taylor's allowance rate?

78.1% of resolved applications examined by Marissa Envenesia Taylor were allowed (32 resolved cases), compared with 67.2% across Art Unit 3783 over the last five years.

Does an interview help with examiner Marissa Envenesia Taylor?

This examiner's interview lift is +30.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Marissa Envenesia Taylor take to allow a patent?

Applications allowed by Marissa Envenesia Taylor took 1,335 days on average from filing to allowance.

Which art unit does examiner Marissa Envenesia Taylor work in?

Marissa Envenesia Taylor examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month